SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-224416
Filing Date
2021-07-26
Accepted
2021-07-26 17:00:59
Documents
17
Period of Report
2021-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d61746d8k.htm   iXBRL 8-K 31259
2 EX-4.2 d61746dex42.htm EX-4.2 184621
3 EX-5.1 d61746dex51.htm EX-5.1 11635
4 EX-5.2 d61746dex52.htm EX-5.2 63281
8 GRAPHIC g61746g0726205333590.jpg GRAPHIC 1767
9 GRAPHIC g61746g0726205333762.jpg GRAPHIC 1768
  Complete submission text file 0001193125-21-224416.txt   475618

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rprx-20210726.xsd EX-101.SCH 2916
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20210726_lab.xml EX-101.LAB 17374
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20210726_pre.xml EX-101.PRE 10969
10 EXTRACTED XBRL INSTANCE DOCUMENT d61746d8k_htm.xml XML 3304
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 211114803
SIC: 2834 Pharmaceutical Preparations